Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2018 Sep 18;293(44):17107–17118. doi: 10.1074/jbc.RA118.005475

A single residue switch reveals principles of antibody domain integrity

Benedikt Weber , Matthias J Brandl , María Daniela Pulido Cendales §, Carolin Berner , Tejaswini Pradhan , Gina Maria Feind , Martin Zacharias §, Bernd Reif , Johannes Buchner ‡,1
PMCID: PMC6222096  PMID: 30228183

Abstract

Despite their importance for antibody architecture and design, the principles governing antibody domain stability are still not understood in sufficient detail. Here, to address this question, we chose a domain from the invariant part of IgG, the CH2 domain. We found that compared with other Ig domains, the isolated CH2 domain is a surprisingly unstable monomer, exhibiting a melting temperature of ∼44 °C. We further show that the presence of an additional C-terminal lysine in a CH2 variant substantially increases the melting temperature by ∼14 °C relative to CH2 WT. To explore the molecular mechanism of this effect, we employed biophysical approaches to probe structural features of CH2. The results revealed that Lys101 is key for the formation of three secondary structure elements: the very C-terminal β-strand and two adjacent α-helices. We also noted that a dipole interaction between Lys101 and the nearby α-helix, is important for stabilizing the CH2 architecture by protecting the hydrophobic core. Interestingly, this interaction between the α-helix and C-terminal charged residues is highly conserved in antibody domains, suggesting that it represents a general mechanism for maintaining their integrity. We conclude that the observed interactions involving terminal residues have practical applications for defining domain boundaries in the development of antibody therapeutics and diagnostics.

Keywords: protein folding, protein aggregation, molecular dynamics, nuclear magnetic resonance (NMR), biophysics, immunoglobulin fold, antibody engineering, antibody, protein stability, antibody constant domain, CH2 domain

Introduction

Immunoglobulin G (IgG) is a tetramer of two identical light and two identical heavy chains. These contain two and four Ig domains, respectively. The Fc region of IgGs consists of two constant heavy chain domains called constant heavy chain 2 (CH2)2 and constant heavy chain 3 (CH3). Both domains have been shown to play a key role in mediating effector functions and preserving antibody stability (1, 2). Understanding the elements that govern the stability of antibody domains is of key interest. So far, mainly the hydrophobic core of the β-barrel and the disulfide bridge have been considered in this context (3, 4). Recently, we found for the variable light chain (VL) domain that residues at the very termini (Ile2 and Arg108) are important for the integrity of the domain (5, 6). Furthermore, the constant light chain (CL) domain was destabilized when the N-terminal Arg108 was deleted (6). To test the concept of a stabilizing effect of terminal residues on the Ig-fold, we turned to the conserved CH2 domain of the Fc fragment. As a typical antibody domain, the CH2 domain exhibits the highly conserved “Ig-fold,” consisting of two β-sheets creating a Greek-key β-barrel, which is stabilized by a disulfide bond in the hydrophobic core (7). Here, we analyzed the conformational stability of a recombinantly expressed murine IgG CH2 domain derived from the murine mAb MAK33, whose individual domains and fragments have been the object of a number of studies (813). Other than the VL and CL domains, CH2 is N- and C-terminally flanked by other antibody domains, the CH1 and CH3 domains, respectively. Analysis of the folding pathway and the structure of the MAK33 CH2 domain showed that the isolated CH2 domain is a monomer with a low structural stability compared with other antibody domains (14, 15). Surprisingly, it was reported that a human IgG CH2 domain can be stabilized by deleting seven residues at the N terminus (16). Thus, the elements governing the stability of the CH2 domain are still enigmatic. Here, we investigated the impact of C-terminal amino acid extensions on the stability of the immunoglobulin-fold with a view to understand the mechanisms that govern the stability of antibody domains. This is of particular interest in the context of therapeutic and diagnostic antibodies because the CH2 domain is currently under development as an antibody scaffold, which easily penetrates into tissues mediating effector functions as well as target binding (17, 18). We find that lysine 101 at the C terminus, which is part of a linker connecting CH2 to CH3, plays a crucial role for the stability of the CH2 domain.

Results

The structural elements determining antibody domain stability are not sufficiently understood. For the VL domain, we showed that the nature of the terminal residues is important for its integrity (5, 6). To test the impact of C-terminal residues on an antibody domain that is followed by a linker and another Ig domain, we chose the MAK33 IgG1 CH2 domain. CH2 variants in this study were extended by amino acids naturally occurring C terminally of the MAK33 CH2 domain, i.e. they connect it to the CH3 domain (14, 19) (Fig. 1, A and B). In total, we investigated four variants, CH2 WT (henceforth referred to as “CH2”) and variants extended by one to four residues: CH2-S, CH2-SK, and CH2-SKTK.

Figure 1.

Figure 1.

Secondary, tertiary and quaternary structure analysis of CH2 variants. A, scheme of CH2 variants. B, cartoon representation of the MAK33 CH2-SKTK isolated from the Fc fragment (PDB 3HKF, includes CH2 and CH3) with indicated termini, intramolecular disulfide bond (yellow), tryptophan residues (orange), and C-terminal residues (Ser100, red; Lys101, green; Thr102 and Lys103, blue). Far (C) and near (D) UV CD spectra of CH2 variants. All variants share the same WT-like secondary structure. The tertiary structure, however, exhibits significant differences between the CH2 variants with maximal distinction between 275 and 295 nm, which indicates changes in the tertiary structure especially for Trp residues. E, SEC-MALS experiments exhibit monomers as the prevalent species for all CH2 variants. Only a small oligomer fraction (<7%) was found. Hence, terminal extensions of the CH2 domains do not alter the quaternary structure.

Terminally extended CH2 variants reveal changes in the tertiary structure

To test whether the CH2 variants are properly folded, we recorded far- and near-UV CD spectra (Fig. 1, C and D). The far-UV spectra of all CH2 variants exhibit two minima at approximately 210 and 230 nm and are highly similar, indicating identical secondary structures for all variants studied (Fig. 1C). Thus, up to four additional residues at the C terminus do not lead to changes in the secondary structure of CH2. However, near-UV CD spectra show a significant change in ellipticity, particularly between 275 and 295 nm compared with the WT protein (Fig. 1D). These wavelengths are indicative of changes in the environment of aromatic residues, particularly Tyr and Trp (20, 21). Because there are no Tyr residues in CH2, the differences seem to occur in the microenvironment of the Trp residues. There are two Trp residues present in CH2, Trp40 and Trp76 (Fig. 1B). Trp40 is part of a β-strand in close proximity to the intramolecular disulfide bond between Cys24 and Cys84. Its side chain is buried in the hydrophobic core of CH2. Trp76 is located in a solvent-exposed α-helix structurally close to the C terminus (14). Trp40 is highly conserved in all antibody domains, whereas Trp76 is conserved in Ig domains, which are part of the Fc fragment (7).

CH2 WT is known to be almost exclusively monomeric (15). We tested whether the CH2 variants were affected in their oligomeric state by size-exclusion chromatography coupled to multiangle light scattering (SEC-MALS). All investigated variants shared a similar elution profile with one major and one minor peak (Fig. 1E). MALS proved all variants to be more than 93% monomeric with a calculated molecular mass between 11.1 and 12.0 kDa for the monomers (Table 1). Because the oligomer concentration was too low, we could not determine a molecular mass of the minor peak. We found a monomer/oligomer ratio for the CH2 variants between 100/0% and 94/6%. There was no correlation of the C-terminal extension and the oligomeric state; only CH2 and CH2-SKTK, the shortest and the longest variants tested, respectively, exhibited a small fraction of oligomers.

Table 1.

Stability and oligomeric state of CH2 variants

Melting temperatures (Tm) were determined by CD thermal unfolding. Chemical unfolding midpoints (D1/2) derived from GdmCl equilibrium unfolding experiments, using intrinsic Trp fluorescence as a probe. Tm and D1/2 represent the mean of three and two individual measurements, respectively. Representative thermal and chemical transitions are shown in Fig. 2. The molecular masses and relative oligomer distribution were determined by SEC-MALS in duplicates using 50 μm protein samples. Representative SEC-MALS chromatograms are shown in Fig. 1E. Given errors indicate the standard deviation.

Variant Tm D1/2 Molecular mass of prevalent species Relative distribution monomer:oligomer
°C m kDa %
CH2 wt 44.4 ± 0.7 1.14 ± 0.03 11.1 ± 0.3 95:5
CH2-S 43.6 ± 0.4 0.92 ± 0.02 11.1 ± 0.2 100:0
CH2-SK 58.6 ± 0.2 1.62 ± 0.04 12.0 ± 1.4 99:1
CH2-SKTK 60.1 ± 0.2 1.65 ± 0.03 11.3 ± 0.3 94:6

Taken together, all CH2 variants exhibit WT-like secondary and quaternary structures, but differences in the tertiary structure compared with the WT. Our data indicate a change in the environment of the Trp residues, suggesting that either one or both Trp residues are located differently in the CH2 extension variants.

The C-terminal Lys101 strongly increases the conformational stability of CH2

To determine the conformational stability of the variants, we performed thermal (Fig. 2A) and chemical (Fig. 2B) unfolding transitions. CH2 WT starts to unfold already at ∼20 °C with a melting temperature (Tm) of 44.4 °C (Table 1). CH2-S is slightly less stable, revealing a Tm of 43.6 °C. Surprisingly, CH2-SK exhibits a significantly higher Tm of 58.6 °C. Hence, CH2-SK is ∼14 °C more stable than CH2 and CH2-S. Thus, this strong increase in stability is accomplished by adding a single Lys residue (Lys101), which is part of the native linker connecting CH2 with CH3 in the full-length antibody (Fig. 1B). CH2-SKTK, comprising two more linker residues, showed a Tm of 60.1 °C, which represents an additional stabilization of ∼1.5 °C compared with CH2-SK. All spectra show similar unfolding cooperativity. To complement the thermal transitions, we performed chemical equilibrium unfolding by probing intrinsic tryptophan fluorescence intensity in the presence of increasing concentrations of guanidinium chloride (GdmCl). Disulfide bonds are known to quench the intrinsic fluorescence of adjacent Trp residues (here Trp40, Fig. 1B) in Ig-fold proteins (22). Thus, unfolding results in an increase in fluorescence intensity. In agreement with the literature, CH2 fluorescence emission increased upon denaturation (15). The experiments revealed a low stability (transition midpoint (D1/2) 1.14 m) for CH2, whereas CH2-SK and CH2-SKTK were similarly stable with a D1/2 of 1.62 and 1.65 m, respectively (Fig. 2B and Table 1). As observed for thermal transitions, CH2-S was less stable against chemical unfolding (D1/2 0.92 m) than CH2. Using the latter method, the difference between CH2 and CH2-S was more pronounced. Thus, for all variants, the order of stability is the same as observed in thermal unfolding experiments. Also, the chemical unfolding transitions feature similar cooperativities. Among all tested CH2 variants, CH2-SKTK showed the highest stability followed by CH2-SK. As observed in the thermal unfolding transitions, the presence of Lys101 resulted in a strong increase in conformational stability, proving that Lys101 makes a strong contribution to the integrity of the CH2 domain. Additional residues of the CH3 linker (Thr102 and Lys103) increase thermal and chemical resilience slightly further. In contrast, Ser100 seems to slightly decrease the conformational stability.

Figure 2.

Figure 2.

Stability of CH2 variants. A, thermal, and B, chemical equilibrium unfolding transitions of CH2 variants reveal a significant impact of the C-terminal Lys101 on the conformational stability. For chemical denaturation, aliquots of the CH2 variants were incubated for at least 12 h with increasing concentrations of GdmCl and monitored by intrinsic tryptophan fluorescence.

Terminal extensions alter the structure and compactness of CH2

To study the local environment of the Trp residues in more detail, we recorded intrinsic tryptophan fluorescence emission spectra. We detected different emission intensities as well as shifted maximum emission wavelengths between the natively folded CH2 variants (Fig. 3A, solid lines). CH2-S and CH2-SKTK display the highest intensities, followed by CH2-SK and CH2. Because the fluorescence intensity is correlated to intrinsic quenching and exposure of the Trp residues, variations most likely reveal differences in the local environment. CH2 and CH2-S (both 338 nm) as well as CH2-SK and CH2-SKTK (both 331 nm) share the same maximum of the emission peak wavelength, respectively. Variants containing Lys101 (CH2-SK and CH2-SKTK) exhibit a pronounced blue shift of ∼8 nm, which is characteristic for a more hydrophobic surrounding of Trp (23). Blue shifts and altered fluorescence intensities indicate different microenvironments of one or both Trp residues for CH2 variants. Because the two Trp residues are probes for the hydrophobic core (Trp40) and for a solvent-exposed α-helix close to the C terminus (Trp76) (Fig. 1B), the structural changes can be assigned to the inner protein core and the α-helix. However, we cannot discriminate between the effects of the two Trp residues. After equilibrium unfolding in the presence of GdmCl, all CH2 variants exhibit the same Trp spectra including intensities (Fig. 3A, dotted lines).

Figure 3.

Figure 3.

Conformational differences of CH2 variants. A, intrinsic tryptophan fluorescence of both, Trp40 and Trp76, probes conformational changes. All folded CH2 variants (solid lines) display different Trp fluorescence intensities at the same concentration (7 μm). However, variants extended by Lys101 feature altered emission maxima with a significant blue shift of ∼8 nm compared with CH2 WT and CH2-S. For comparison, all variants show identical spectra when unfolded using 3.8 m GdmCl (dotted lines). B, Stern-Volmer plots show different acrylamide quenching profiles for CH2 variants. The introduction of the C-terminal Lys101 (CH2-SK and CH2-SKTK) leads to a significantly lower ability of acrylamide to quench intrinsic Trp fluorescence. Thus, Lys101 alters the accessibility of the Trp residues.

To gain further insight in conformational changes within the CH2 variants, we quenched the Trp fluorescence using acrylamide (Fig. 3B). This allowed us to evaluate the accessibility of both Trp residues and therefore of the hydrophobic core and the α-helix close to the C terminus. CH2 and CH2-S featured a strong exponential relationship between fluorescence signal and acrylamide concentration. An acrylamide concentration of 0.1 m caused a ∼2.2-fold Trp fluorescence quenching. For 1 m acrylamide, we observed 37- and 40-fold lower Trp emission intensities for CH2 and CH2-S, respectively. Accordingly, CH2-SK and CH2-SKTK exhibit Stern-Volmer plots, which are flatter and less exponential than for the variants without Lys101. Interestingly, the presence of Lys101 at the C terminus significantly changed the quenching intensity, indicating an altered accessibility for both Trp residues. Exponential Stern-Volmer correlations suggest distinct accessibility of the quencher for two fluorophores within one protein (24, 25). In contrast, linear plots indicate equal accessibility of acrylamide for two tryptophanes. Thus, the less pronounced the exponential growth, the more similar are the dynamics of both Trp residues. The Trp residues of CH2 variants containing Lys101 feature ∼2-fold less quenching than CH2 variants without Lys101, proving their lower accessibility for acrylamide. Most likely, this alteration is due to a more compact microenvironment of the Trp residues in the presence of Lys101. However, we cannot discriminate between the impact of Trp40 and Trp76 on the fluorescence emission. In summary, CH2-SK and CH2-SKTK experience locally distinct structural differences compared with WT and CH2-S, which is attributed to the presence of Lys101.

Lys101 shields core area and helical structure in its proximity

To reveal differences in protein dynamics and structure, we performed hydrogen/deuterium exchange (HDX) experiments followed by mass spectrometric analysis of CH2 and CH2-SKTK (Fig. 4). Along the entire primary structure, CH2 showed higher deuterium uptake than CH2-SKTK for all time points (Fig. S1). To focus on the HDX level alterations between CH2 and CH2-SKTK, we calculated the relative uptake ratio (CH2/CH2-SKTK) and plotted it against the residue number of the CH2 sequence (Fig. 4A). For distinct regions, particularly the α-helix and its extension (residues 70–81) we observed pronounced differences in the relative uptake level (Fig. 4, region 3). These differences are mainly localized in structural vicinity of the C-terminal region of CH2 (Fig. 4B). We observed no substantial effects for the N-terminal part, but a slightly decreased HDX for another nearby α-helix (residue 8 to 15; Fig. 4, region 1). Particularly two regions, from Pro70 to Glu81 and surprisingly Trp40 revealed strongly decreased HDX levels for CH2-SKTK compared with WT (Fig. 4, regions 2 and 3). For Trp40, we were able to achieve pseudo-single residue resolution by HDX because we obtained peptides differing only in the presence or absence of Trp40 (Fig. S2). The affected α-helix (Met72–Asn78) in proximity to the C terminus is located between the two Ig-fold characteristic β-strands E and F, which are together with β-strands B and C define the hydrophobic core (26, 27). Thus, both β-sheets making up the β-sandwich-like Ig-fold in constant domains (CFG and ABED) experience decreased dynamics due to the presence of Lys101. Moreover, the very C-terminal residue (Fig. 4, region 4) exhibits a decreased HDX slightly more pronounced than the first helix (residues 8–15). Among the residues that experienced altered HDX are Trp40 and Trp76 as indicated by acrylamide quenching.

Figure 4.

Figure 4.

HDX experiments to probe protein dynamics. A, relative fractional uptake ratio for CH2/CH2-SKTK reveals pronounced altered HDX levels up to 2.3-fold for distinct regions. Data represent the mean of two individual experiments for each variant; shadows indicate standard deviation. B, relative uptake ratio for CH2/CH2-SKTK displayed on the crystal structure of CH2 (PDB 3HKF). Color gradient from blue (no difference) to red (2.3-fold decrease in exchange relative to CH2) indicates structural and dynamical alteration between CH2 and CH2-SKTK. Four distinct regions display pronounced differences caused by the presence of SKTK at the C terminus. Black: no HDX data available for these residues. HDX experiments for the shown data were quenched after 10 s of exchange.

In summary, we found the C-terminal extension of SKTK to impact the dynamics and local structure of a number of secondary structure elements. By correlating the HDX data with unfolding transitions, we can map the effect on Lys101 because this residue is responsible for the strong increase in conformational stability. Important elements of the Ig-fold, which are part of the hydrophobic core and connected by an α-helix, are affected by the C-terminal presence of Lys101, indicating a more compact and protected protein core.

The presence of Lys101 leads to a more structured helix and C-terminal region

1H,15N-Heteronuclear single quantum coherence NMR experiments as well as 1H,13C,15N-triple resonance experiments were performed using WT CH2 and the variant EV-CH2-SK. For the NMR analysis, the variant EV-CH2-SK has been employed, because it gave better spectra. The N-terminal extension of the protein did not impact the overall conformation of the CH2 domain (Fig. S3–S6). Additionally, the conformational stability of EV-CH2-SK is not substantially affected by the two introduced N-terminal residues (Fig. S7).

Differences in backbone amide 1H and 15N chemical shifts for CH2 and the variant EV-CH2-SK are indicative for conformational differences (Fig. 5A). In contrast to substantial 1H,15N-chemical shift changes for residues in the C-terminal region (residues 95–99), we observed no assignable resonances for most residues located in the α-helical regions (residues 10–14 and 72–78). This suggests that these regions change their mode of interaction upon the presence of the Lys101. Consistent with that, HDX experiments identified all three regions to be impacted by Lys101 (Fig. 4). Moreover, we found intense chemical shift changes for residues capping the α-helices (residues 15–16 and 71–72), which showed less intense HDX (Fig. 4B, regions 1 and 3).

Figure 5.

Figure 5.

NMR chemical shift changes for CH2 and EV-CH2-SK. A, 1H,15N-chemical shift differences observed for CH2 and EV-CH2-SK. The largest changes in chemical shifts occur in the C-terminal part of the protein, whereas the α-helical region involving residues 10–14 and 72–78 could not be assigned for CH2 WT. Residue numbering was according to the CH2 WT sequence. Asterisks indicate unassigned residues. B, 13Cα chemical shift differences δ(13C, experimental) − δ(13C, random coil). Random coil chemical shifts were taken from Wishart and Sykes (28). Positive values indicate propensity for an α-helix, negative values for a β-strand. The top panel shows the chemical shift differences for WT CH2, the bottom panel for EV-CH2-SK. Blue and red bars at the bottom of the lower panel show the secondary structure as indicated in the crystal structure (PDB 3HKF), full height shaded areas highlight the major changes in secondary structure propensity. The secondary chemical shifts of assignable residues in the extended variant indicate the presence of two stable α-helices in the regions between residues 10–14 and 73–80 in EV-CH2-SK. These residues probably show dynamics on a time scale that makes the residues unresolvable by NMR in the WT. In addition, the C-terminal region of EV-CH2-SK shows propensity to form a β-strand, whereas the same region in the WT appears more likely to occupy a random coil conformation. Asterisks indicate unassigned residues.

Analysis of the 13Cα chemical shift of the two proteins yields information on changes in the local secondary structure propensity (28, 29). Positive Δ13Cα chemical shift differences (δ(experimental) − δ(random coil)) are indicative for formation of helical structure, whereas negative shift differences suggest the population of β-sheet structure. Of notice, the crystal structure of the CH2 domain is derived from the entire Fc fragment, comprising CH2 including Lys101 and CH3. Comparing the two CH2 variants, we observe helical propensity for residues 10–13 and 73–80 in EV-CH2-SK, whereas there were no assignable resonances for the respective residues in the WT (Fig. 5B, results for alternative sets of random coil shifts are provided in Fig. S8–S10). This is in agreement with our finding that HDX is substantially decreased for these regions of CH2-SKTK (Fig. 4) and suggests that the α-helices visible in these regions in the crystal structure (PDB 3HKF) only form in presence of Lys101. In addition, the negative secondary chemical shifts observed for the C-terminal region (residues 95–99) is indicative of the formation of a β-strand in EV-CH2-SK that is visible in the crystal structure, but not present in the WT. These additional secondary structure elements, two α-helices and β-strand, contribute to the overall stabilization of the protein observed in the presence of Lys101 (Fig. 2).

Lys101-helix dipole interactions induces conformational rigidity

Molecular dynamics (MD) simulations were performed on the WT, and the extended variants CH2-S and CH2-SK in explicit solvent. On a time scale of 1 μs, the structures stayed close to the X-ray structure starting geometry with a root mean square deviation of the protein backbone of <2.5 Å (Fig. S11) and no signs of unfolding. However, in the case of the CH2 WT and CH2-S, slight shifts in conformation and increased fluctuations were observed compared with CH2-SK. To relate the simulations to experimentally observed differences in HDX (Fig. 4) we calculated the mean solvent accessibility of each residue in the proteins during the whole data gathering phase (after the simulation equilibration phase) (Fig. 6). Because the HDX probability is expected to depend on the solvent accessibility, this quantity might be well-suited for comparison to the experiment. Indeed, the simulations predict an increased mean solvent accessibility of the region between residues 65 and 80, which corresponds to the short α-helical segment in the vicinity of the C-terminal Lys101 residue. The absence of this stabilizing interaction with the helix dipole in case of the CH2 WT and CH2-S likely influences also the conformation and flexibility of the helical segment and in turn causes an increased HDX for CH2 and CH2-S. Interestingly, the simulations indicate that this is mostly due to a conformational shift and not necessarily due to increased mobility (Fig. S11).

Figure 6.

Figure 6.

Mean solvent accessibility during MD simulations. The ratio in mean SASA of residues in CH2 WT relative to CH2-SK (green) and relative to CH2-SKTK (blue) was calculated for each residue over a simulation period of 1 μs at 300 K. A SASA ratio >1 indicates increased mean accessibility relative to CH2-SK or relative to CH2-SKTK, respectively (obtained as sliding window average over 10 consecutive residues).

To explain the reduced stability of the CH2 WT and CH2-S compared with the CH2-SK variant, we performed umbrella sampling (US) free energy simulations along the reaction coordinate that results in dissociation of the C-terminal segment from the folded β-strand to form a fully solvated conformation (see “Experimental procedures”). Such a transition indicates the free energy contribution of the C-terminal region to stabilize the folded structure. The difference between the calculated free energy for the variants versus the WT is a measure of the loss in stabilization due to the presence of the folded C-terminal strand.

The simulations predict a similar reduced stabilization of CH2 and CH2-S relative to CH2-SK and CH2-SKTK, respectively, by ∼4 kcal mol−1 (compare the difference in plateau-free energy values reached in case of CH2 and CH2-S versus CH2-SK and CH2-SKTK variants upon dissociation of the C-terminal strand in Fig. 7). The significant free energy difference in favor of the CH2-SK and CH2-SKTK variants agrees qualitatively well with the observed differences in melting temperature of the two variants versus WT. Inspection of snapshots from different US windows indicates that the origin of the free energy difference seems to be indeed the interaction of the Lys101 side chain with the adjacent helical segment (residues 72–81). This interaction is still visible in the intermediate US windows that result in the largest free energy increase (Fig. 7). At the same US intervals, the C terminus of the WT or the CH2-S variant are already dissociated. Hence, the presence of the Lys101-helix dipole interaction results in an increase of the potential of mean force (PMF) and stabilizes the folded state significantly.

Figure 7.

Figure 7.

Calculated free energy change upon dissociation of the C-terminal β-strand from its placement in the folded structure to a solvated unfolded state. The free energy change (PMF) was calculated along a reaction coordinate that corresponds to the center of mass distance of backbone atoms of the C-terminal segment (delimited by residues 94 to 98) and the backbone atoms of the protein (delimited by residues 1 to 91). Representative snapshots taken in the folded, intermediate, and dissociated states of the C-terminal segment are indicated (color-code of the cartoon representation corresponds to the line color in the plot). The C-terminal Lys residue in CH2-SK is indicated as van der Waals sphere representation and still interacts with the helical segment (residues 72–81) in the intermediate state (at which the C terminus of the CH2 WT is already fully dissociated).

Discussion

Here, we determined the impact of residues located C-terminally of the CH2 domain in IgG1 on its conformational stability and protein dynamics. Importantly, the investigated terminal residues (SKTK) are not part of defined secondary structure elements as shown in the crystal structure (Fig. 1B, PDB 3HKF). The presence of these residues resulted in a pronounced stability increase of ∼14 °C. By assessing CH2 variants extended by one to four residues, we were able to attribute this strong stabilizing effect to a single residue: Lys101. This was rather unexpected, as residues of the β-sandwich would have been the most likely suspects for determining the stability of the domain. Our analysis revealed a complex interaction pattern that maintains the integrity of the domain. HDX experiments showed significantly decreased dynamics for the α-helix connecting the β-strands E and F. This α-helix links both β-sheets, which make up the characteristic Ig-fold β-barrel. As a consequence, the hydrophobic core is more compact and this results in an overall higher structural integrity as also indicated by the different microenvironments of the two Trp residues. In this context, our NMR experiments demonstrated that this important α-helix is not stably formed in the absence of Lys101, which is further supported by increased HDX and surface solvent accessibility (SASA) in this region. In addition, our HDX and NMR data show decreased dynamics for the second α-helix connecting β-strands A and B. Interestingly, this α-helix is in close structural proximity to the aforementioned α-helix. Thus, the polar interaction between the α-helix dipole and Lys101 is required to initiate and maintain stable α-helices. Moreover, for CH2-SK, the secondary structure propensity analysis indicates the formation of the very C-terminal β-strand G only in the presence of Lys101. As the three secondary structure elements are all dependent on Lys101, this residue is a key determinant for the overall conformational stability. In agreement with the experimental data, our simulations indicate that the Lys101 interaction with the nearby α-helix makes a significant free energy contribution in favor of the folded state. Feige et al. (30) showed that the rapid folding of the α-helical structures in antibody domains orientates the two β-sheets in a favorable way. In this context, the interaction of Lys101 with the α-helix and the formation of the second α-helix in CH2 initiate the native folding pathway by assuring the proper orientation of the residues forming the hydrophobic core and the β-sheets, specifically β-strands E and F. The conserved polar interaction between Lys101 and the α-helix dipole indicates a stabilizing effect of Lys101 on the Ig-fold, mediated by the α-helix between β-strands E and F (7). Thus, in addition to the intramolecular disulfide bonding, the α-helix between strands E and F, stabilized by Lys101, makes an important contribution. By sequential and structural alignment, we found that Lys101, or alternatively another positively charged residue like arginine, and its interaction with the adjacent α-helix is conserved among constant Ig domains except CL and CH1 of which the latter one is natively unfolded (Fig. S12) (31). Interestingly, C-terminal charged residues of CH1 interact with an α-helix of CL when associated in a Fab fragment (PDB 2QSC and 3OZ9), potentially affecting the conformational stability of both domains. Moreover, CLλ comprises a C-terminal Glu followed by a highly conserved Cys, which connects the light chain with the heavy chain by linking CL and CH1 (PDB 2FB4). Thus, except for CL and CH1, the structural feature identified in this study seems to be evolutionarily favored to assure the proper initiation of folding and conformational stability of other constant Ig domains. Traditionally, the formation of a hydrophobic core is seen as the main stabilizing interaction that determines the folding and stability of a globular protein (3234). However, the conserved polar interaction between a positively charged side chain and an α-helix (dipole) at the surface of the CH2 domain also make a significant contribution to stability as shown by our free energy simulations and unfolding studies. A solvent-protected core, optimally oriented β-sheets, and proper folding of secondary structure elements like the interacting α-helix and a C-terminal β-strand are thus important factors for structural integrity and explain the strong increase in conformational stability. A strong stabilization by an interaction between an α-helix dipole and a residue, which is not part of this α-helix has not been observed before. However, a stabilizing effect of α-helices by charged residues within the same α-helix, particularly Glu and Lys capping the α-helix, has been reported (3537).

Our results also raise the question how to determine immunoglobulin domain boundaries correctly. When the first Ig domain sequences were described, various individual domains were aligned, e.g. murine CH1, CH2, CH3, and CH4, derived from different Ig isoforms (IgM, IgD, IgG, etc.) (38, 39). This method revealed significant homology between the different domains such as conserved cysteines and tryptophanes along with other residues (40). In parallel, it was found that every constant domain is encoded by an individual exon, which raised evidence for a separation of the domains already on the genetic level (41). Hence, the first and last residues of constant domains are determined by RNA splicing (42). This strategy of defining Ig domain boundaries was supported by structural data (43). In contrast to the constant domains, the structures of the VH and VL domains have been described in detail to systematically assign framework regions and complementary determining regions, of which the latter ones facilitate antigen binding (44, 45). As antibody folding and stability were primarily attributed to the hydrophobic core, the conserved disulfide bond, and the characteristic β-strands, domain boundaries lost relevance (3, 7, 22, 26, 46). However, as we showed for a murine VLκ, the N- and C-terminal residues, i.e. Ile2 and Arg108 play a major role for the integrity of the domain (5, 6). Together with other recent data (16), this revives the question of domain boundaries, especially in the context of the increased use of antibody fragments as diagnostics and therapeutics. Historically, during the early development of single chain variable fragments, the boundaries of VL, VH, Fc, and CH3 were randomly set by optimizing the position of the linker between both domains with respect to the orientation of the two domains within the heterodimer (47, 48). Biophysically optimized rather than genetically determined N and C termini might serve as a complementary method to increase the conformational stability of antibody fragments by terminal residue-based α-helix stabilization resulting in lower aggregation propensity, improved pharmacokinetics, and shelf life. This approach might thus contribute to more stable, reliable therapeutics and diagnostics and is potentially applicable for engineering of other constant antibody domains. Therefore, we propose to consider the impact of N- and C-terminal linker residues for defining Ig domain boundaries. Taken together, the Ig-fold is not only maintained by intramolecular disulfides and the packing of the hydrophobic core. Ionic interactions of surface-exposed residues play an important role to facilitate and maintain proper folding of the conserved α-helix and in turn the β-barrel structure, thereby protecting the hydrophobic core and assuring conformational stability.

Experimental procedures

Oligonucleotides were purchased from MWG Biotech (Ebersberg, Germany). All chemicals were obtained from Merck (Darmstadt, Germany) or Sigma. Unless otherwise stated all measurements were carried out in PBS buffer (pH 7.4) at 25 °C.

Cloning, mutagenesis, expression, and purification

The CH2 encoding plasmid was previously described (15). Subcloning of the CH2 WT gene into the pET28b expression vector (Merck/Novagen, Darmstadt, Germany) was performed using sequence- and ligation-independent cloning (SLIC) (49) and transformed into Escherichia coli BL21 (DE3)-star cells (Invitrogen). CH2 variants were generated utilizing overhang primers with SLIC (50). For modifications, we used PCR primers with an appropriate 5′ overhang in the reverse primer. Success of subcloning and mutagenesis was verified by sequencing. Added residues are indicated by the one letter code behind the WT domain name, e.g. CH2-SKTK.

All variants were expressed and purified as previously described for antibody VL domains (5). Briefly, cells were grown in LBKan medium to an A600 of 0.6–0.8 at 37 °C. Overnight protein expression was induced by 1 mm isopropyl 1-thio-β-d-galactopyranoside. For NMR experiments, expression of 15N-labeled or 13C,15N-labeled proteins was performed in M9 minimal medium containing 15NH4Cl and glucose or [13C]glucose (Cambridge Isotope Laboratories Inc., Andover, MA), respectively. Cells were harvested the next day and inclusion bodies were prepared as previously described (51). Inclusion bodies were solubilized and denatured in 50 mm Tris-HCl (pH 8.0), 10 mm EDTA, 8 m urea, 0.1% 2-mercaptoethanol and subsequently purified using a Q-Sepharose column (GE Healthcare, Uppsala, Sweden), followed by a Superdex 75 16/60 gel filtration column (GE Healthcare). Between the two purification steps, the proteins at a concentration of approximately 1 mg/ml were refolded overnight by dialysis against 250 mm Tris-HCl (pH 8.0), 100 mm l-Arg, 5 mm EDTA, 1 mm oxidized GSH, and 0.5 mm reduced GSH at 4 °C. Protein purity and identity were verified by SDS-PAGE.

Circular dichroism spectroscopy

CD measurements were performed using a Jasco J-715 spectropolarimeter (Jasco, Grossumstadt, Germany) equipped with a Peltier element. Near- and far-UV CD spectra were measured using 50 or 10 μm protein in a 2- or 1-mm path length quartz cuvette between 320 and 260 nm or 260 and 200 nm wavelengths, respectively. Spectra were accumulated 16 times, buffer-corrected, and normalized for mean residue molar ellipticity. Thermal transitions were recorded using 10 μm protein in a 1-mm path length quartz cuvette at 215 nm wavelength with a heating rate of 30 °C/h. Transitions were fitted using a Boltzmann function.

SEC-MALS

The oligomeric state of CH2 variants was determined using a GE Superdex 75 10/300 GL column connected to a Shimadzu HPLC system (Shimadzu, Munich, Germany) equipped with Shimadzu Refractive Index- and UV-detectors as well as a Wyatt Dawn Helios II multiangle light scattering detector (Wyatt Technology, Dernbach, Germany). The column was equilibrated for at least 24 h to obtain a stable MALS detector baseline prior to data collection. Inter-detector delay volumes, band broadening, light-scattering detector normalization, and the instrument calibration coefficient were set using 1 mg/ml of BSA (Sigma, Munich, Germany) in PBS according to standard protocols. 50 μl of 50 μm protein samples was loaded on the column. All experiments were performed at room temperature at a flow rate of 0.45 ml/min in PBS (pH 7.4), 0.05% NaN3. The molecular mass and mass distribution of CH2 were determined using the ASTRA 5 software (Wyatt Technology, Dernbach, Germany).

Intrinsic tryptophan fluorescence spectroscopy

Intrinsic tryptophan fluorescence spectra were measured with 7 μm protein in a 1-cm quartz cuvette at 22 °C using a Jasco FP-6500 spectrofluorometer (Jasco, Grossumstadt, Germany). Fluorescence emission spectra were recorded between 300 and 400 nm with an excitation wavelength of 280 nm. Slits were set to 5 nm for both excitation and emission. All spectra were recorded two times, averaged and normalized.

For chemical equilibrium unfolding transitions, we incubated 5 μm protein with increasing concentrations of GdmCl for at least 12 h at room temperature in black 96-well microplates (number 655809, Greiner Bio-One). Tryptophan fluorescence spectra of protein samples incubated with either 0 or 4 m GdmCl were recorded the next day. By subtracting the two spectra we determined the maximal differential emission wavelength (357 nm), which was set constant for measuring the fluorescence intensity of all samples at 22 °C. Fixed wavelength measurements were performed using an Infinite M Nano microplate reader (Tecan Group Ltd., Männedorf, Switzerland). Equilibrium unfolding transitions were fit as described before (52).

For acrylamide quenching, increasing concentrations of acrylamide were added to 5 μm protein and incubated overnight at room temperature to assure quenching equilibrium. Spectra were measured as described above. Fixed wavelength measurements were carried out using 280 and 338 nm for excitation and emission, respectively. F0 represents the fluorescence intensity without any acrylamide. The calculated Stern-Volmer quotient F0/F, where F is the fluorescence intensity at the respective acrylamide concentration shows the accessibility of a CH2 variant for acrylamide (24, 25).

HDX-mass spectrometry

HDX-MS experiments were performed using a fully automated system equipped with a Leap PAL RTC (LEAP Technologies, NC), a Waters ACQUITY M-Class UPLC, a HDX manager, and the Synapt G2-S electrospray ionization TOF mass spectrometer (Waters Corp.), as described elsewhere (53). Protein samples with a concentration of 30 μm were diluted 1:20 with deuterium oxide in PBS (pH 7.4) and incubated at 20 °C for 10 s, 1 min, 10 min, 30 min, and 2 h. To stop the labeling reaction and denature the sample, the labeled protein was diluted 1:1 in quenching buffer (200 mm Na2HPO4 × 2H2O, 200 mm NaH2PO4 × 2H2O; 250 mm tris(2-carboxyethyl)phosphine, 3 m GdmCl, pH 2.2) at 1 °C. Digestion was performed on a Waters Enzymate BEH Pepsin Column (2.1 × 30 mm) at 20 °C. Peptides were trapped and subsequently separated on a Waters ACQUITY UPLC BEH C18 column (1.7 μm, 1.0 × 100 mm) with acetonitrile plus 0.1% formic acid (v/v) and H2O plus 0.1% formic acid (v/v) gradients. Trapping and chromatographic separation were carried out at 0 °C to minimize back-exchange. Eluting peptides were directly subjected to the TOF mass spectrometer by electrospray ionization. Before fragmentation by MSE and mass detection in resolution mode, the peptide ions were additionally separated by drift time within the mobility cell. Data processing was performed using the Waters Protein Lynx Global Server PLGS (version 3.0.3) and DynamX (version 3.0).

NMR spectroscopy

1H,15N-Heteronuclear single quantum coherence NMR spectra, as well as 1H,13C,15N-triple resonance spectra were acquired on a Bruker AVIII 500 or 600 MHz spectrometer with a cryogenic triple resonance gradient probe. The respective 15N- or 13C,15N-labeled proteins were dissolved in PBS buffer supplemented with 10% D2O. Backbone assignments were based on three-dimensional HNCA (5456), HNCACB (57, 58), and HN(CO)CACB (58, 59) spectra. All spectra were processed using Bruker TopSpin, and analyzed using CcpNmr (60). The protein concentrations were in the range of 60–1200 μm for two-dimensional experiments and in the range of 600–1200 μm for three-dimensional experiments.

1H,15N-Chemical shift perturbations (Δδ) were calculated as (61),

Δδ1H,15N=12(Δδ1H2+(0.14Δδ15N)2) (Eq. 1)

with ΔδNuc = δVariant 1 − δVariant 2. 13C-Chemical shift perturbations relative to a random coil peptide (secondary chemical shifts) were calculated using the difference between the observed chemical shift and the random coil chemical shift for the respective residue type (28).

MD simulations

MD simulations were carried out and analyzed using the Amber16 simulation package (67). Free unrestrained MD simulations and US simulations were performed to analyze the stability of the CH2 antibody domain employing the pmemd.cuda module of Amber16 (62). Simulations were performed on the WT CH2 as well as variants CH2-S and CH2-SK (all based on the crystal structure PDB 3HKF). Each protein was solvated in TIP3P water (63) in a periodic octahedron box with a minimum distance of protein atoms to the box boundary of 10 Å. The ff14SB force field was employed and Na+ and Cl ions were added to neutralize the system and reach an ion concentration of 0.15 m. Energy minimization of each system was performed with the sander module of Amber16 (1500 minimization cycles). The systems were heated in steps of 100 K (10 ps per step) to a final temperature of 300 K with the solute nonhydrogen atoms harmonically restraint to the start structure. All bonds involving hydrogen atoms were kept at optimal length. In additional 6 steps the harmonic restraints were removed stepwise. For the production simulations (i.e. started from structures at equilibrium gained from the previous equilibration phase) hydrogen mass repartitioning was employed allowing a time step of 4 fs (instead of 2 fs used during heating and equilibration). Unrestrained production simulations were extended to 1 μs for each system. Coordinates were saved every 2 ps. The root mean square deviation from the experimental structure and SASA, using the LCPO algorithm (64), were calculated using the Amber cpptraj module. The change in mean SASA per residue was calculated as difference of average SASA (per residue) of each variant versus WT. It was smoothed by averaging the results over a window of 10 consecutive residues along the whole sequence.

By using the US method (65), it is possible to efficiently extract free energy changes along a coordinate of interest by forcing it to overcome possible energy barriers. To estimate the influence of the C-terminal β-strand segment (residues 94–98) on the folding stability of the protein, we defined the reaction coordinate as the distance d between the centers of mass of the C terminus (delimited by residues 94 to 98) and the rest of the protein (delimited by residues 1 to 91). The C terminus of the protein can be dissociated gradually by applying a harmonic penalty potential with the force constant K around a reference distance dref. A total of 25 umbrella windows with different values for K and dref were simulated for each biomolecule to obtain overlapping histograms in d for reliable calculation of the potential of mean force (PMF: free energy change along d). The three sets of generated umbrella windows were: (i) 11 consecutive simulations with dref varying between 10.0 and 20.0 Å with a step of 1.0 Å and a force constant of K = 2.5 kcal/Å2 mol, (ii) 11 consecutive simulations with dref varying between 12.0 and 17.0 Å with a step of 0.5 Å and a force constant of K = 3.5 kcal/Å2 mol, (iii) 3 consecutive simulations with dref varying between 12.5 and 13.5 Å with a step of 0.5 Å and a force constant of K = 5.0 kcal/Å2 mol. In each umbrella window, simulations of 50 ns at 300 K were performed (time step 2 fs), whereby positional restraints with a force constant of Kpos = 0.02 kcal/Å2 mol were applied to nonhydrogen atoms in residues 1–91. A PMF along the reaction coordinate d was calculated using the WHAM algorithm (66).

Author contributions

B. W., M. Z., B. R., and J. B. conceptualization; B. W., M. J. B., M. D. P. C., and G. M. F. formal analysis; B. W. and J. B. validation; B. W., M. J. B., M. D. P. C., C. B., T. P., and G. M. F. investigation; B. W. visualization; B. W., M. J. B., M. D. P. C., M. Z., and B. R. methodology; B. W., M. J. B., M. Z., B. R., and J. B. writing-original draft; M. Z., B. R., and J. B. resources; M. Z. software; M. Z., B. R., and J. B. funding acquisition; M. Z., B. R., and J. B. project administration; J. B. supervision.

Supplementary Material

Supporting Information

Acknowledgments

We thank Lisa Schweizer and Sebastian Schuler for help with the biophysical experiments.

This work was supported by an individual grant from the DFG (to J. B.); the DFG Grant SFB-1035, projects B07 (to B. R.) and B02 (to M. Z.); Helmholtz-Gemeinschaft (to B. R.); and Center for Integrated Protein Science Munich (CIPS-M). The authors declare that they have no conflicts of interest with the contents of this article.

This article contains Figs. S1–S12.

Backbone 1H,15N,13C-chemical shift assignments have been deposited in the Biological Magnetic Resonance Data Bank with accession numbers 27584 and 27585.

2
The abbreviations used are:
CH
constant heavy chain
VL
variable light
CL
constant light chain
SEC-MALS
size-exclusion chromatography coupled to multiangle light scattering
GdmCl
guanidinium chloride
HDX
hydrogen/deuterium exchange
MD
molecular dynamics
US
umbrella sampling
PMF
potential of mean force
SASA
solvent-accessible surface area
PDB
Protein Data Bank.

References

  • 1. Tao M. H., Canfield S. M., and Morrison S. L. (1991) The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain. J. Exp. Med. 173, 1025–1028 10.1084/jem.173.4.1025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Morgan A., Jones N. D., Nesbitt A. M., Chaplin L., Bodmer M. W., and Emtage J. S. (1995) The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, FcγRI and FcγRIII binding. Immunology 86, 319–324 [PMC free article] [PubMed] [Google Scholar]
  • 3. Liu H., and May K. (2012) Disulfide bond structures of IgG molecules. MAbs 4, 17–23 10.4161/mabs.4.1.18347 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Wagschal K., Tripet B., Mant C., Hodges R. S., and Lavigne P. (1999) The role of position a in determining the stability and oligomerization state of α-helical coiled coils: 20 amino acid stability coefficients in the hydrophobic core of proteins. Protein Sci. 8, 2312–2329 10.1110/ps.8.11.2312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Nokwe C. N., Zacharias M., Yagi H., Hora M., Reif B., Goto Y., and Buchner J. (2014) A residue-specific shift in stability and amyloidogenicity of antibody variable domains. J. Biol. Chem. 289, 26829–26846 10.1074/jbc.M114.582247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Nokwe C. N., Hora M., Zacharias M., Yagi H., John C., Reif B., Goto Y., and Buchner J. (2015) The antibody light-chain linker is important for domain stability and amyloid formation. J. Mol. Biol. 427, 3572–3586 10.1016/j.jmb.2015.09.012 [DOI] [PubMed] [Google Scholar]
  • 7. Feige M. J., Hendershot L. M., and Buchner J. (2010) How antibodies fold. Trends Biochem. Sci. 35, 189–198 10.1016/j.tibs.2009.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Feige M. J., Simpson E. R., Herold E. M., Bepperling A., Heger K., and Buchner J. (2010) Dissecting the alternatively folded state of the antibody Fab fragment. J. Mol. Biol. 399, 719–730 10.1016/j.jmb.2010.04.032 [DOI] [PubMed] [Google Scholar]
  • 9. Nokwe C. N., Hora M., Zacharias M., Yagi H., Peschek J., Reif B., Goto Y., and Buchner J. (2016) A stable mutant predisposes antibody domains to amyloid formation through specific non-native interactions. J. Mol. Biol. 428, 1315–1332 10.1016/j.jmb.2016.01.015 [DOI] [PubMed] [Google Scholar]
  • 10. Simpson E. R., Herold E. M., and Buchner J. (2009) The folding pathway of the antibody VL domain. J. Mol. Biol. 392, 1326–1338 10.1016/j.jmb.2009.07.075 [DOI] [PubMed] [Google Scholar]
  • 11. Thies M. J., Mayer J., Augustine J. G., Frederick C. A., Lilie H., and Buchner J. (1999) Folding and association of the antibody domain CH3: prolyl isomerization preceeds dimerization. J. Mol. Biol. 293, 67–79 10.1006/jmbi.1999.3128 [DOI] [PubMed] [Google Scholar]
  • 12. Feige M. J., Hagn F., Esser J., Kessler H., and Buchner J. (2007) Influence of the internal disulfide bridge on the folding pathway of the CL antibody domain. J. Mol. Biol. 365, 1232–1244 10.1016/j.jmb.2006.10.049 [DOI] [PubMed] [Google Scholar]
  • 13. Lilie H. (1997) Folding of the Fab fragment within the intact antibody. FEBS Lett. 417, 239–242 10.1016/S0014-5793(97)01293-3 [DOI] [PubMed] [Google Scholar]
  • 14. Feige M. J., Nath S., Catharino S. R., Weinfurtner D., Steinbacher S., and Buchner J. (2009) Structure of the murine unglycosylated IgG1 Fc fragment. J. Mol. Biol. 391, 599–608 10.1016/j.jmb.2009.06.048 [DOI] [PubMed] [Google Scholar]
  • 15. Feige M. J., Walter S., and Buchner J. (2004) Folding mechanism of the CH2 antibody domain. J. Mol. Biol. 344, 107–118 10.1016/j.jmb.2004.09.033 [DOI] [PubMed] [Google Scholar]
  • 16. Gong R., Wang Y., Ying T., Feng Y., Streaker E., Prabakaran P., and Dimitrov D. S. (2013) N-terminal truncation of an isolated human IgG1 CH2 domain significantly increases its stability and aggregation resistance. Mol. Pharm. 10, 2642–2652 10.1021/mp400075f [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Dimitrov D. S. (2009) Engineered CH2 domains (nanoantibodies). MAbs 1, 26–28 10.4161/mabs.1.1.7480 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Gehlsen K., Gong R., Bramhill D., Wiersma D., Kirkpatrick S., Wang Y., Feng Y., and Dimitrov D. S. (2012) Pharmacokinetics of engineered human monomeric and dimeric CH2 domains. MAbs 4, 466–474 10.4161/mabs.20652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Buckel P., Hübner-Parajsz C., Mattes R., Lenz H., Haug H., and Beaucamp K. (1987) Cloning and nucleotide sequence of heavy- and light-chain cDNAs from a creatine-kinase-specific monoclonal antibody. Gene 51, 13–19 10.1016/0378-1119(87)90469-0 [DOI] [PubMed] [Google Scholar]
  • 20. Boxer D. H., Zhang H., Gourley D. G., Hunter W. N., Kelly S. M., and Price N. C. (2004) Sensing of remote oxyanion binding at the DNA binding domain of the molybdate-dependent transcriptional regulator, ModE. Org. Biomol. Chem. 2, 2829–2837 10.1039/b404185b [DOI] [PubMed] [Google Scholar]
  • 21. Kelly S. M., Jess T. J., and Price N. C. (2005) How to study proteins by circular dichroism. Biochim. Biophys. Acta 1751, 119–139 10.1016/j.bbapap.2005.06.005 [DOI] [PubMed] [Google Scholar]
  • 22. Goto Y., and Hamaguchi K. (1979) The role of the intrachain disulfide bond in the conformation and stability of the constant fragment of the immunoglobulin light chain. J. Biochem. 86, 1433–1441 10.1093/oxfordjournals.jbchem.a132661 [DOI] [PubMed] [Google Scholar]
  • 23. Vivian J. T., and Callis P. R. (2001) Mechanisms of tryptophan fluorescence shifts in proteins. Biophys. J. 80, 2093–2109 10.1016/S0006-3495(01)76183-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Phillips S. R., Wilson L. J., and Borkman R. F. (1986) Acrylamide and iodide fluorescence quenching as a structural probe of tryptophan microenvironment in bovine lens crystallins. Curr. Eye Res. 5, 611–619 10.3109/02713688609015126 [DOI] [PubMed] [Google Scholar]
  • 25. Tallmadge D. H., Huebner J. S., and Borkman R. F. (1989) Acrylamide quenching of tryptophan photochemistry and photophysics. Photochem. Photobiol. 49, 381–386 10.1111/j.1751-1097.1989.tb09183.x [DOI] [PubMed] [Google Scholar]
  • 26. Bork P., Holm L., and Sander C. (1994) The immunoglobulin fold: structural classification, sequence patterns and common core. J. Mol. Biol. 242, 309–320 10.1006/jmbi.1994.1582 [DOI] [PubMed] [Google Scholar]
  • 27. Wang J. H. (2013) The sequence signature of an Ig-fold. Protein Cell 4, 569–572 10.1007/s13238-013-3903-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Wishart D. S, and Sykes B. D. (1994) The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J. Biomol. NMR 4, 171–180 [DOI] [PubMed] [Google Scholar]
  • 29. Spera S., and Bax A. (1991) Empirical correlation between protein backbone conformation and Cα and Cβ 13C nuclear magnetic resonance chemical shifts. J. Am. Chem. Soc. 113, 5490–5492 10.1021/ja00014a071 [DOI] [Google Scholar]
  • 30. Feige M. J., Groscurth S., Marcinowski M., Yew Z. T., Truffault V., Paci E., Kessler H., and Buchner J. (2008) The structure of a folding intermediate provides insight into differences in immunoglobulin amyloidogenicity. Proc. Natl. Acad. Sci. U.S.A. 105, 13373–13378 10.1073/pnas.0802809105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Feige M. J., Groscurth S., Marcinowski M., Shimizu Y., Kessler H., Hendershot L. M., and Buchner J. (2009) An unfolded CH1 domain controls the assembly and secretion of IgG antibodies. Mol. Cell 34, 569–579 10.1016/j.molcel.2009.04.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Pace C. N. (1992) Contribution of the hydrophobic effect to globular protein stability. J. Mol. Biol. 226, 29–35 10.1016/0022-2836(92)90121-Y [DOI] [PubMed] [Google Scholar]
  • 33. Di Nardo A. A., Larson S. M., and Davidson A. R. (2003) The relationship between conservation, thermodynamic stability, and function in the SH3 domain hydrophobic core. J. Mol. Biol. 333, 641–655 10.1016/j.jmb.2003.08.035 [DOI] [PubMed] [Google Scholar]
  • 34. Munson M., Balasubramanian S., Fleming K. G., Nagi A. D., O'Brien R., Sturtevant J. M., and Regan L. (1996) What makes a protein a protein? hydrophobic core designs that specify stability and structural properties. Protein Sci. 5, 1584–1593 10.1002/pro.5560050813 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Wolny M., Batchelor M., Bartlett G. J., Baker E. G., Kurzawa M., Knight P. J., Dougan L., Woolfson D. N., Paci E., and Peckham M. (2017) Characterization of long and stable de novo single α-helix domains provides novel insight into their stability. Sci. Rep. 7, 44341 10.1038/srep44341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Marqusee S., and Baldwin R. L. (1987) Helix stabilization by Glu−·Lys+ salt bridges in short peptides of de novo design. Proc. Natl. Acad. Sci. U.S.A. 84, 8898–8902 10.1073/pnas.84.24.8898 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Richardson J. S., and Richardson D. C. (1988) Amino acid preferences for specific locations at the ends of α helices. Science 240, 1648–1652 10.1126/science.3381086 [DOI] [PubMed] [Google Scholar]
  • 38. Kehry M., Sibley C., Fuhrman J., Schilling J., and Hood L. E. (1979) Amino acid sequence of a mouse immunoglobulin μ chain. Proc. Natl. Acad. Sci. U.S.A. 76, 2932–2936 10.1073/pnas.76.6.2932 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Shimizu A., Takahashi N., Yamawaki-Kataoka Y., Nishida Y., Kataoka T., and Honjo T. (1981) Ordering of mouse immunoglobulin heavy chain genes by molecular cloning. Nature 289, 149–153 10.1038/289149a0 [DOI] [PubMed] [Google Scholar]
  • 40. Dayhoff M. (1978) Atlas of Protein Sequence and Structure, National Biomedical Research Foundation, Silver Spring, MD [Google Scholar]
  • 41. Sakano H., Rogers J. H., Hüppi K., Brack C., Traunecker A., Maki R., Wall R., and Tonegawa S. (1979) Domains and the hinge region of an immunoglobulin heavy chain are encoded in separate DNA segments. Nature 277, 627–633 10.1038/277627a0 [DOI] [PubMed] [Google Scholar]
  • 42. Rabbitts T. H., Forster A., and Milstein C. P. (1981) Human immunoglobulin heavy chain genes: evolutionary comparisons of Cμ, Cδ and Cγ genes and associated switch sequences. Nucleic Acids Res. 9, 4509–4524 10.1093/nar/9.18.4509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Poljak R. J., Amzel L. M., Avey H. P., Chen B. L., Phizackerley R. P., and Saul F. (1973) Three-dimensional structure of the Fab′ fragment of a human immunoglobulin at 2.8-Å resolution. Proc. Natl. Acad. Sci. U.S.A. 70, 3305–3310 10.1073/pnas.70.12.3305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Kabat E. A., Te Wu T., Foeller C., Perry H. M., and Gottesman K. S. (1992) Sequences of Proteins of Immunological Interest, Fifth Ed., pp. 103–257 and pp. 310–494, Diane Publishing, Darby, PA [Google Scholar]
  • 45. Chothia C., Gelfand I., and Kister A. (1998) Structural determinants in the sequences of immunoglobulin variable domain. J. Mol. Biol. 278, 457–479 10.1006/jmbi.1998.1653 [DOI] [PubMed] [Google Scholar]
  • 46. Goto Y., and Hamaguchi K. (1981) Formation of the intrachain disulfide bond in the constant fragment of the immunoglobulin light chain. J. Mol. Biol. 146, 321–340 10.1016/0022-2836(81)90391-0 [DOI] [PubMed] [Google Scholar]
  • 47. Bird R., Hardman K., Jacobson J., Johnson S., Kaufman B., Lee S., Lee T., Pope S., Riordan G., and Whitlow M. (1988) Single-chain antigen-binding proteins. Science 242, 423–426 10.1126/science.3140379 [DOI] [PubMed] [Google Scholar]
  • 48. Alt M., Müller R., and Kontermann R. E. (1999) Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin γ1 Fc or CH3 region. FEBS Lett. 454, 90–94 10.1016/S0014-5793(99)00782-6 [DOI] [PubMed] [Google Scholar]
  • 49. Li M. Z., and Elledge S. J. (2012) SLIC: a method for sequence- and ligation-independent cloning. Methods Mol. Biol. 852, 51–59 10.1007/978-1-61779-564-0_5 [DOI] [PubMed] [Google Scholar]
  • 50. Jeong J.-Y., Yim H.-S., Ryu J.-Y., Lee H. S., Lee J.-H., Seen D.-S., and Kang S. G. (2012) One-step sequence- and ligation-independent cloning as a rapid and versatile cloning method for functional genomics studies. Appl. Environ. Microbiol. 78, 5440–5443 10.1128/AEM.00844-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Thies M. J., and Pirkl F. (2000) Chromatographic purification of the CH2 domain of the monoclonal antibody MAK33. J. Chromatogr. B Biomed. Sci. Appl. 737, 63–69 10.1016/S0378-4347(99)00377-1 [DOI] [PubMed] [Google Scholar]
  • 52. Santoro M. M., and Bolen D. W. (1988) Unfolding free energy changes determined by the linear extrapolation method: 1. unfolding of phenylmethanesulfonyl α-chymotrypsin using different denaturants. Biochemistry 27, 8063–8068 10.1021/bi00421a014 [DOI] [PubMed] [Google Scholar]
  • 53. Zhang A., Hu P., MacGregor P., Xue Y., Fan H., Suchecki P., Olszewski L., and Liu A. (2014) Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling. Anal. Chem. 86, 3468–3475 10.1021/ac404130a [DOI] [PubMed] [Google Scholar]
  • 54. Schleucher J., Sattler M., and Griesinger C. (1993) Coherence selection by gradients without signal attenuation: application to the three-dimensional HNCO experiment. Angew. Chemie Int. Ed. English 32, 1489–1491 10.1002/anie.199314891 [DOI] [Google Scholar]
  • 55. Grzesiek S., and Bax A. D. (1992) Improved 3D triple-resonance NMR techniques applied to a 31 kDa protein. J. Magn. Reson. 96, 432–440 10.1016/0022-2364(92)90099-S [DOI] [Google Scholar]
  • 56. Kay L. E., Xu G. Y., and Yamazaki T. (1994) Enhanced-sensitivity triple-resonance spectroscopy with minimal H2O saturation. J. Magn. Reson. Ser. A 109, 129–133 10.1006/jmra.1994.1145 [DOI] [Google Scholar]
  • 57. Wittekind M., and Mueller L. (1993) HNCACB, a high-sensitivity 3D NMR experiment to correlate amide-proton and nitrogen resonances with the α- and β-carbon resonances in proteins. J. Magn. Reson. Ser. B 101, 201–205 10.1006/jmrb.1993.1033 [DOI] [Google Scholar]
  • 58. Muhandiram D. R., and Kay L. E. (1994) Gradient-enhanced triple-Resonance three-dimensional NMR experiments with improved sensitivity. J. Magn. Reson. Ser. B 103, 203–216 10.1006/jmrb.1994.1032 [DOI] [Google Scholar]
  • 59. Grzesiek S., and Bax A. (1993) Amino acid type determination in the sequential assignment procedure of uniformly 13C/15N-enriched proteins. J. Biomol. NMR. 3, 185–204 [DOI] [PubMed] [Google Scholar]
  • 60. Vranken W. F., Boucher W., Stevens T. J., Fogh R. H., Pajon A., Llinas M., Ulrich E. L., Markley J. L., Ionides J., and Laue E. D. (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins Struct. Funct. Genet. 59, 687–696 10.1002/prot.20449 [DOI] [PubMed] [Google Scholar]
  • 61. Williamson M. P. (2013) Using chemical shift perturbation to characterise ligand binding. Prog. Nucl. Magn. Reson. Spectrosc. 73, 1–16 10.1016/j.pnmrs.2013.02.001 [DOI] [PubMed] [Google Scholar]
  • 62. Götz A. W., Williamson M. J., Xu D., Poole D., Le Grand S., and Walker R. C. (2012) Routine microsecond molecular dynamics simulations with AMBER on GPUs: 1. generalized born. J. Chem. Theory Comput. 8, 1542–1555 10.1021/ct200909j [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Jorgensen W. L., Chandrasekhar J., Madura J. D., Impey R. W., and Klein M. L. (1983) Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 10.1063/1.445869 [DOI] [Google Scholar]
  • 64. Weiser J., Shenkin P. S., and Still W. C. (1999) Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J. Comput. Chem. 20, 217–230 10.1002/(SICI)1096-987X(19990130)20:2%3C217::AID-JCC4%3E3.0.CO%3B2-A [DOI] [Google Scholar]
  • 65. Kästner J. (2011) Umbrella sampling, Wiley Interdisciplinary Reviews: computational molecular science. Wiley Interdiscip. Rev. Comput. 1, 932–942 10.1002/wcms.66 [DOI] [Google Scholar]
  • 66. Kumar S., Rosenberg J. M., Bouzida D., Swendsen R. H., and Kollman P. A. (1992) The weighted histogram analysis method for free energy calculations on biomolecules: I. the method. J. Comput. Chem. 13, 1011–1021 10.1002/jcc.540130812 [DOI] [Google Scholar]
  • 67. Case D. A., Betz R. M., Cerutti D. S., Cheatham T. E. III, Darden T. A., Duke R. E., Giese T. J., Gohlke H., Goetz A. W., Homeyer N., Izadi S., Janowski P., Kaus J., Kovalenko A., Lee T. S., et al. (2016) AMBER 2016, University of California, San Franciso, CA [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES